Literature DB >> 23607612

Pressure pain sensitivity: a new method of stress measurement in patients with ischemic heart disease.

Natasha Bergmann1, Søren Ballegaard, Pernille Holmager, Jesper Kristiansen, Finn Gyntelberg, Lars J Andersen, Åke Hjalmarson, Per Bech, Lars Arendt-Nielsen, Jens Faber.   

Abstract

BACKGROUND: Chronic stress is prevalent in patients with ischemic heart disease (IHD) and worsens the long-term prognosis. Chronic stress is vaguely defined, but is associated with depressive symptoms, reduced psychological wellbeing, and reduced quality of life (QOL). Stress seems to induce hyperalgesia.The aim of the present study was to evaluate hyperalgesia by pressure pain sensitivity (PPS) in patients with IHD, and compare PPS to questionnaires measuring depressive symptoms, reduced psychological wellbeing, and QOL as markers of stress. Design. A cross-sectional study of 361 subjects with IHD.
METHODS: PPS was measured on the sternum, and compared to the questionnaires: Clinical stress symptoms score (CSS), Major Depression Inventory (MDI), WHO-5 Wellbeing Index, and SF-36 QOL score.
RESULTS: PPS correlated to CSS (r = 0.20, p < 0.001), MDI (r = 0.14, p = 0.02), SF-36 mental component summary score (MCS) (r = - 0.10, p = 0.049), SF-36 physical component summary score (PCS) (r = - 0.17, p = 0.001), and self-perceived stress level (r = 0.15, p = 0.006). CSS correlated similarly (r = 0.5-0.7, all p < 0.001). Comparing subjects within the lowest vs. highest tertiles of PPS and CSS, the mean MDI score was 4 vs. 15, WHO-5 was 77 vs. 53, SF-36 PCS was 53 vs. 43, and SF-36 MCS was 58 vs. 46; all p < 0.001.
CONCLUSIONS: PPS reflected to a modest degree markers of chronic stress in IHD. PPS and CSS together might be useful as easy-to use tools for evaluating these markers in IHD patients.

Entities:  

Mesh:

Year:  2013        PMID: 23607612     DOI: 10.3109/00365513.2013.785588

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

1.  Reduction of Pressure Pain Sensitivity as Novel Non-pharmacological Therapeutic Approach to Type 2 Diabetes: A Randomized Trial.

Authors:  Jens Faber; Ebbe Eldrup; Christian Selmer; Caroline Pichat; Sofie Korsgaard Hecquet; Torquil Watt; Svend Kreiner; Benny Karpatschof; Finn Gyntelberg; Søren Ballegaard; Albert Gjedde
Journal:  Front Neurosci       Date:  2021-03-11       Impact factor: 4.677

2.  Diabetes and ischemic heart disease: double jeopardy with regard to depressive mood and reduced quality of life.

Authors:  Natasha Bergmann; Søren Ballegaard; Pernille Holmager; Per Bech; Ake Hjalmarson; Finn Gyntelberg; Jens Faber
Journal:  Endocr Connect       Date:  2014-08-19       Impact factor: 3.335

3.  The effect of daily self-measurement of pressure pain sensitivity followed by acupressure on depression and quality of life versus treatment as usual in ischemic heart disease: a randomized clinical trial.

Authors:  Natasha Bergmann; Søren Ballegaard; Per Bech; Ake Hjalmarson; Jesper Krogh; Finn Gyntelberg; Jens Faber
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

4.  Home-based aerobic exercise in patients with lacunar stroke: Design of the HITPALS randomized controlled trial.

Authors:  Rikke Steen Krawcyk; Anders Vinther; Nicolas Caesar Petersen; Jens Faber; Rasmus Hvass Hansen; Egill Rostrup; Christina Kruuse
Journal:  Contemp Clin Trials Commun       Date:  2019-02-02

5.  Validation of the WHO-5 Well-Being Scale among Adolescents in Ghana: Evidence-Based Assessment of the Internal and External Structure of the Measure.

Authors:  Frank Quansah; John Elvis Hagan; Francis Ankomah; Edmond Kwesi Agormedah; Regina Mawusi Nugba; Medina Srem-Sai; Thomas Schack
Journal:  Children (Basel)       Date:  2022-07-01

6.  Patients with symptomatic permanent atrial fibrillation show quantitative signs of pain sensitisation.

Authors:  Adam Jackson; Ole Frobert; Dennis Boye Larsen; Lars Arendt-Nielsen; Anna Björkenheim
Journal:  Open Heart       Date:  2021-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.